Abstract P2-01-02: Heterogeneity and variability of human epidermal growth factor receptor 2 (HER2) expression on circulating tumor cells (CTC) in HER2 negative metastatic breast cancer patients treated with first line weekly paclitaxel and bevacizumab in a prospective cohort from the French Breast Cancer InterGroup Unicancer (UCBG): COMET study

Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Her2 Expression ◽

Breast Cancer Patients ◽

First Line ◽

Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients

Breast Cancer Research ◽

10.1186/bcr1788 ◽

2007 ◽

Vol 9 (6) ◽

Cited By ~ 50

Author(s):

Kristjan S Asgeirsson ◽

Amit Agrawal ◽

Claire Allen ◽

Anthony Hitch ◽

Ian O Ellis ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Her2 Expression ◽

Breast Cancer Patients ◽

Abstract P3-04-03: Identification, clinical characteristics and treatment outcomes of somatic human epidermal growth factor receptor 2 (ERBB2) mutations in metastatic breast cancer patients

10.1158/1538-7445.sabcs17-p3-04-03 ◽

2018 ◽

Author(s):

L Jongen ◽

G Floris ◽

D Lambrechts ◽

A Laenen ◽

P Neven ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Clinical Characteristics ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Abstract P3-01-04: DETECT V – Expression analysis of human epidermal growth factor receptor 2 and estrogen receptor on circulating tumor cells of metastatic breast cancer patients

10.1158/1538-7445.sabcs18-p3-01-04 ◽

2019 ◽

Author(s):

T Fehm ◽

F Meier-Stiegen ◽

S Riethdorf ◽

B Rack ◽

F-A Taran ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Lapatinib Versus Placebo Added to Paclitaxel in First-Line Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Ethical Lessons Not Learned From Africa

Journal of Clinical Oncology ◽

10.1200/jco.2013.51.0289 ◽

2013 ◽

Vol 31 (33) ◽

pp. 4271-4271 ◽

Cited By ~ 2

Author(s):

Felipe Ades

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

First Line ◽

Human Epidermal Growth Factor ◽

Abstract PS9-54: Healthcare costs for metastatic breast cancer patients treated with human epidermal growth factor receptor 2 targeted agents

10.1158/1538-7445.sabcs20-ps9-54 ◽

2021 ◽

Author(s):

Reshma Mahtani ◽

Deepa Lalla ◽

Nina Oestreicher ◽

Augustina Ogbonnaya ◽

Vishal Saundankar ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Healthcare Costs ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Targeted Agents ◽

Breast Cancer Patients ◽

Abstract P1-01-15: DETECT V - Detection of the expression of estrogen receptor and human epidermal growth factor receptor 2 on circulating tumor cells from metastatic breast cancer patients

10.1158/1538-7445.sabcs16-p1-01-15 ◽

2017 ◽

Author(s):

T Fehm ◽

F Meier-Stiegen ◽

S Riethdorf ◽

A Schramm ◽

A Polasik ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Abstract P2-03-05: Identification, clinical characteristics and treatment outcomes of somatic human epidermal growth factor receptor 2 (ERBB2) mutations in metastatic breast cancer patients

10.1158/1538-7445.sabcs16-p2-03-05 ◽

2017 ◽

Author(s):

L Jongen ◽

G Floris ◽

D Lambrechts ◽

A Laenen ◽

P Neven ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Clinical Characteristics ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Limited human epidermal growth factor receptor 2 discordance in metastatic breast cancer patients treated with trastuzumab, a population based study

European Journal of Cancer ◽

10.1016/j.ejca.2014.01.010 ◽

2014 ◽

Vol 50 (5) ◽

pp. 885-891 ◽

Cited By ~ 5

Author(s):

J.M. van Rooijen ◽

L. de Munck ◽

J.C. de Graaf ◽

S. Siesling ◽

E.G. de Vries ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Population Based ◽

Breast Cancer Patients ◽

Population Based Study ◽

Trends in the choice of first line treatment for hormone - responsive (HR+), human epidermal growth factor receptor - 2 negative (HER2-) metastatic breast cancer (MBC) patients (pts): results of a multicentric Italian observational study

Annals of Oncology ◽

10.1093/annonc/mdx424 ◽

2017 ◽

Vol 28 ◽

pp. vi25

Author(s):

A. D' Alonzo ◽

C. Bighin ◽

F. Puglisi ◽

L. Gerratana ◽

M. De Laurentis ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Epidermal Growth ◽

First Line Treatment

DETECT V – expression of human epidermal growth factor receptor 2 and estrogen receptor on circulating tumor cells of metastatic breast cancer patients

10.1055/s-0038-1651759 ◽

2018 ◽

Author(s):

F Meier-Stiegen ◽

S Riethdorf ◽

B Rack ◽

FA Taran ◽

K Pantel ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽